quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:15·745d
SECFiling
NGM Biopharmaceuticals Inc. logo

SEC Form EFFECT filed by NGM Biopharmaceuticals Inc.

NGM· NGM Biopharmaceuticals Inc.
Health Care
Original source

Companies

  • NGM
    NGM Biopharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Mar 12UpdateRaymond James-
  • Feb 28UpdateTD Cowen-
  • Feb 27UpdateCitigroup-
  • May 3UpdateCitigroup$6.00
  • Oct 18UpdateGoldman$4.00
  • Oct 18UpdateRaymond James$4.00

Related

  • PR288d
    Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer
  • SEC738d
    SEC Form 15-12G filed by NGM Biopharmaceuticals Inc.
  • INSIDER745d
    Tcg Opportunity Iii Gp, Llc returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)
  • INSIDER745d
    Column Group Gp, Lp returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)
  • INSIDER745d
    Column Group L P returned 21,743,413 shares to the company and acquired 1,000 shares (SEC Form 4)
  • INSIDER745d
    Goeddel David V returned 22,008,593 shares to the company and acquired 1,000 shares, closing all direct ownership in the company (SEC Form 4)
  • INSIDER745d
    Pierce Valerie L closing all direct ownership in the company (SEC Form 4)
  • INSIDER745d
    Rieflin William Jl closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022